axlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusse

  • SATT AxLR
    • SATT AxLR
    • Governance
    • Services for companies
    • Annual reports
  • Assisting you
    • Researchers
      • Call-for-projects
    • Companies
    • Startups
    • Practical guide
  • Technology offerings
    • Invest
      • In our technologies
      • In our startups
    • Technologies
    • Startups
    • AxLR TV
  • Working with AxLR
    • Purchasing & public procurement
    • Join us
    • Our startups are hiring
  • Media
    • News
    • Agenda
    • Press kit
    • Communication kit
  • Contact
English
  • French
✕
  • Home
  • ALPHA-CENTAURI
PL-VAC
13 October 2019
HPCG
30 July 2019

ALPHA-CENTAURI

ALPHA-CENTAURI

New high-throughput screening technique for molecules modulating innate immunity signaling pathways

Available technology

IP

  • Know-how

Establishment(s)

  • University of Montpellier
  • CNRS

Laboratory(ies)

  • IRIM (Montpellier Infectiology Research Institute) - UMR 9004

Keywords

  • Innate immunity
  • Infectious diseases
  • Cancer

Context

Innate immunity is the body's first line of defense against the infectious and pathogenic agents that surround us. The cell signaling pathways involved in activating innate immune system cells involve the nuclear translocation of two transcription factors, NF-kappaB and IRF3, which induce the expression of pro-inflammatory cytokines and type 1 interferon, respectively. Many tools have been developed to screen molecules according to their ability to modulate innate immune response, but the scientific community is in general agreement that the sensitivity and specificity of these tests are not sufficient.

Benefits

This project’s main goal is to develop innovative tools for quantifying the nuclear translocation of transcription factors (IRF3 and NF-kappaB) for innate immunity by complementing protein fragments. The developed technique, called Alpha-Centauri, not only makes it possible to screen molecules in a high throughput format (HTS) quickly and easily, but has also proven its superiority over existing tests in terms of specificity and sensitivity.

Applications

Screening molecules that may be potential drugs against infections, cancer, fibrosis, rheumatoid arthritis, neurodegenerative disorders, chronic lung diseases, etc.

AVAILABLE TECHNOLOGY | Innate immunity – Infectious diseases – Cancer

Share
0

Related posts

8 September 2021

StabCFTR


En savoir +
6 July 2021

HTLV-1


En savoir +
23 June 2021

GEOSOTECH


En savoir +
© 2023, AxLR - SATT Occitanie Méditerranée. All rights reserved. | Legal terms & Privacy policy
English
  • English
  • French